Who Owns Crescent Biopharma Stock?
NASDAQ: CBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 82.94%
- Held by insiders
- 0.27%
- Institutional holders
- 122
- Institutions 82.9%
- Insiders 0.3%
- Public and other 16.8%
Who owns Crescent Biopharma stock?
Institutional investors own about 82.9% of Crescent Biopharma's shares, spread across 122 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.27% of CBIO.
The largest institutional holders are FMR, LLC (11.13%), BVF Inc. (7.40%) and Fairmount Funds Management LLC (7.40%). Together, the top 10 institutions control 57.2% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CBIO positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CBIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 4.13M | 11.13% | 0.0% |
| BVF Inc. | 2.75M | 7.40% | 0.0% |
| Fairmount Funds Management LLC | 2.75M | 7.40% | 0.0% |
| Venrock Adviser, LLC | 2.13M | 5.74% | 0.0% |
| Logos Global Management LP | 1.90M | 5.12% | +293.8% |
| FCPM III Services B.V. | 1.68M | 4.52% | 0.0% |
| Balyasny Asset Management LP | 1.66M | 4.48% | +10.1% |
| Vestal Point Capital, LP | 1.63M | 4.39% | +8.7% |
| Opaleye Management Inc. | 1.32M | 3.55% | +0.5% |
| Blackrock Inc. | 1.27M | 3.42% | +999.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CBIO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 661.95K | 1.78% |
| iShares Trust-iShares Russell 2000 ETF | 532.28K | 1.43% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 432.29K | 1.16% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 358.29K | 0.96% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 308.25K | 0.83% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 292.32K | 0.79% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 236.41K | 0.64% |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 221.49K | 0.60% |
| iShares Trust-iShares Russell 2000 Growth ETF | 204.35K | 0.55% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 190.42K | 0.51% |
Frequently asked questions
Who is the largest shareholder of Crescent Biopharma?
FMR, LLC is the largest institutional shareholder of CBIO, owning 11.13% of shares outstanding (4.13M shares) as of its latest 13F filing.
What percentage of Crescent Biopharma is owned by institutions?
Institutions own about 82.9% of CBIO shares and 83.2% of the public float.
How much of Crescent Biopharma do insiders own?
Insiders, such as officers and directors, own about 0.27% of CBIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.